Vascular Biology |
From the Department of Clinical Pharmacology (G.C., A.D.H., M.S., C.D.-M.), National Heart and Lung Institute, Imperial College of Science, Technology, and Medicine, St. Marys Hospital, London, UK; the Ludwig Institute (J.-K.H.), St. Marys Hospital, London, UK; and the Institute of Biology (D.K.), NCSR "Demokritos," Athens, Greece.
Correspondence to Dr A.D. Hughes, Clinical Pharmacology, National Heart and Lung Institute, Imperial College of Science, Technology, and Medicine, St. Marys Hospital, London W2 1NY, UK. E-mail a.hughes{at}ic.ac.uk
AbstractUsing an in vitro model of a conditionally immortalized cell line, we have investigated how human vascular smooth muscle cells (VSMCs) are affected by the expression of simian virus 40 (SV40) large T antigen (LT antigen), which binds to cell cycle regulators such as the tumor suppressor protein p53. Cells were obtained after infection of saphenous vein-derived VSMCs with a nonreplicative retroviral vector containing a temperature-sensitive mutant of SV40 LT antigen and were shown to have maintained some characteristics and responses of VSMCs. Under permissive-temperature conditions (36°C), the increased rate of cell proliferation was shown to be associated with expression of LT antigen and with LT antigen binding to and inactivation of p53. p53 inactivation failed to block apoptosis induced by serum withdrawal or UV irradiation. Downregulation of LT antigen expression at a nonpermissive temperature (39°C) was shown to be associated with growth arrest, increased expression of the cell cycle inhibitor p21WAF1/CIP1, increased murine double minute-2 promoter activity, and differential expression of murine double minute-2 gene products, suggesting that p53-induced transcription/transactivation may be involved in VSMC cycle control but not necessarily in apoptosis. The established SMC line HVTs-SM1 may be a useful model for study of the processes involved in myointimal hyperplasia and cellular aging, as well as for the study of cell cycle control in general.
Key Words: vascular smooth muscle SV-40 p53 MDM2 p21WAF1/CIP1
This article has been cited by other articles:
![]() |
X. J. Lian and I.-E. Gallouzi Oxidative Stress Increases the Number of Stress Granules in Senescent Cells and Triggers a Rapid Decrease in p21waf1/cip1 Translation J. Biol. Chem., March 27, 2009; 284(13): 8877 - 8887. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. I. Patel, S. Daniel, C. R. Longo, G. V. Shrikhande, S. T. Scali, E. Czismadia, C. M. Groft, T. Shukri, C. Motley-Dore, H. E. Ramsey, et al. A20, a modulator of smooth muscle cell proliferation and apoptosis, prevents and induces regression of neointimal hyperplasia FASEB J, July 1, 2006; 20(9): 1418 - 1430. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Van Vleet, T. L. Watterson, P. J. Klein, and R. A. Coulombe Jr. Aflatoxin B1 Alters the Expression of p53 in Cytochrome P450-Expressing Human Lung Cells Toxicol. Sci., February 1, 2006; 89(2): 399 - 407. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhou, J. Li, A. M. Goldsmith, D. C. Newcomb, D. M. Giannola, R. G. Vosk, E. M. Eves, M. R. Rosner, J. Solway, and M. B. Hershenson Human Bronchial Smooth Muscle Cell Lines Show a Hypertrophic Phenotype Typical of Severe Asthma Am. J. Respir. Crit. Care Med., March 15, 2004; 169(6): 703 - 711. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Taurin, V. Seyrantepe, S. N. Orlov, T.-L. Tremblay, P. Thibault, M. R. Bennett, P. Hamet, and A. V. Pshezhetsky Proteome Analysis and Functional Expression Identify Mortalin as an Antiapoptotic Gene Induced by Elevation of [Na+]i/[K+]i Ratio in Cultured Vascular Smooth Muscle Cells Circ. Res., November 15, 2002; 91(10): 915 - 922. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Izawa, J.-i. Suzuki, W. Takahashi, J. Amano, and M. Isobe Tranilast Inhibits Cardiac Allograft Vasculopathy in Association With p21Waf1/Cip1 Expression on Neointimal Cells in Murine Cardiac Transplantation Model Arterioscler Thromb Vasc Biol, July 1, 2001; 21(7): 1172 - 1178. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |